The health effects of nonindustrial indoor air pollution

Journal of Allergy and Clinical Immunology

Volumn 121, Issue 3, 2008, Pages 585-591

  Bernstein, Jonathan A ^a   Alexis, Neil ^b   Bacchus, Hyacinth ^c   Bernstein, I Leonard ^a   Fritz, Pat ^d   Horner, Elliot ^e   Li, Ning ^f   Mason, Stephany ^e   Nel, Andre ^f   Oullette, John ^g   Reijula, Kari ^h   Reponen, Tina ⁱ   Seltzer, James ^j   Smith, Alisa ^k   Tarlo, Susan M ^l  

^a Allergy Section   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c Ministry of Health and the Environment   (United States)

^d RENSSELAER POLYTECHNIC INSTITUTE   (United States)

^e Air Quality Sciences Inc   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g Adult Allergy Clinics   (United States)

^h FINNISH INSTITUTE OF OCCUPATIONAL HEALTH   (Finland)

ⁱ UNIVERSITY OF CINCINNATI   (United States)

^j Sharp Mission Park Medical Group   (United States)

^k U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

^l TORONTO WESTERN HOSPITAL   (Canada)

more..

Author keywords

carbon monoxide; cotinine; fungal allergens; health effects; Indoor air pollutants; nitrogen dioxide; ozone; particulate matter; passive smoke exposure; sulfur dioxide; tobacco smoke; volatile organic compounds

Indexed keywords

ALLERGEN; CARBON MONOXIDE; FORMALDEHYDE; NITROGEN DIOXIDE; OZONE; SULFUR DIOXIDE; TOBACCO SMOKE; VOLATILE ORGANIC COMPOUND;

AIR MONITORING; AIR POLLUTION CONTROL; AIR QUALITY; ALLERGIC DISEASE; AMBIENT AIR; ARTICLE; ASTHMA; ENVIRONMENTAL EXPOSURE; HOME ENVIRONMENT; HUMAN; INDOOR AIR POLLUTION; MICROBIAL CONTAMINATION; NONHUMAN; PARTICULATE MATTER; PASSIVE SMOKING; PRIORITY JOURNAL; RISK ASSESSMENT; VASOMOTOR RHINITIS; WORKPLACE; AIR POLLUTANT; ENVIRONMENTAL MONITORING; METHODOLOGY; REVIEW;

AIR POLLUTANTS; AIR POLLUTION, INDOOR; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL MONITORING; HUMANS; TOBACCO SMOKE POLLUTION;

EID: 40049098469     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2007.10.045     Document Type: Article

References (76)

1. Bernstein J.A., Alexis N., Barnes C., Bernstein I.L., Nel A., Peden D., et al. Health effects of air pollution. J Allergy Asthma Clin Immunol 114 (2004) 116-1123
2. Spengler J., Sundell J., Tanabe S., and Nazaroff B. Editorial: deadly household pollution: a call to action. Indoor Air 16 (2006) 2-3
3. McDonnell W.F. Use of submaximal inhalation and spirometry to assess the effects of ozone exposure. Arch Environ Health 59 (2004) 76-83
4. Alexis N.E., Becker S., Bromberg P.A., Devlin R., and Peden D.B. Circulating CD11b expression correlates with the neutrophil response and airway mCD14 expression is enhanced following ozone exposure in humans. Clin Immunol 111 (2004) 126-131
5. Peden D.B. Air pollution in asthma: effect of pollutants on airway inflammation. Ann Allergy Asthma Immunol 87 (2001) 12-17
6. Molhave L., Kjaergaard S.K., Sigsgaard T., and Lebowitz M. Interaction between ozone and airborne particulate matter in office air. Indoor Air 15 (2005) 383-392
7. Peden D.B., Setzer Jr. R.W., and Devlin R.B. Ozone exposure has both a priming effect on allergen-induced responses and an intrinsic inflammatory action in the nasal airways of perennially allergic asthmatics. Am J Respir Crit Care Med 151 (1995) 1336-1345
8. Hubbard H.F., Coleman B.K., Sarwar G., and Corsi R.L. Effects of an ozone-generating air purifier on indoor secondary particles in three residential dwellings. Indoor Air 15 (2005) 432-444
9. Belanger K., Gent J.F., Triche E.W., Bracken M.B., and Leaderer B.P. Association of indoor nitrogen dioxide exposure with respiratory symptoms in children with asthma. Am J Respir Crit Care Med 173 (2006) 297-303
10. van Strien R.T., Gent J.F., Belanger K., Triche E., Bracken M.B., and Leaderer B.P. Exposure to NO2 and nitrous acid and respiratory symptoms in the first year of life. Epidemiology 15 (2004) 471-478
11. Strand V., Rak S., Svartengren M., and Bylin G. Nitrogen dioxide exposure enhances asthmatic reaction to inhaled allergen in subjects with asthma. Am J Respir Crit Care Med 155 (1997) 881-887
12. Tunnicliffe W.S., Burge P.S., and Ayres J.G. Effect of domestic concentrations of nitrogen dioxide on airway responses to inhaled allergen in asthmatic patients. Lancet 344 (1994) 1733-1736
13. Beckett W.S., Russi M.B., Haber A.D., Rivkin R.M., Sullivan J.R., Tameroglu Z., et al. Effect of nitrous acid on lung function in asthmatics: a chamber study. Environ Health Perspect 103 (1995) 372-375
14. Katsouyanni K., Touloumi G., Spix C., Schwartz J., Balducci F., Medina S., et al. Short-term effects of ambient sulphur dioxide and particulate matter on mortality in 12 European cities: results from time series data from the APHEA project. Air Pollution and Health: A European Approach. BMJ 314 (1997) 1658-1663
15. Leaderer B.P., Naeher L., Jankun T., Balenger K., Holford T.R., Toth C., et al. Indoor, outdoor, and regional summer and winter concentrations of PM10, PM2.5, SO4(2)-, H+, NH4+, NO3-, NH3, and nitrous acid in homes with and without kerosene space heaters. Environ Health Perspect 107 (1999) 223-231
16. Horstman D., Roger L.J., Kehrl H., and Hazucha M. Airway sensitivity of asthmatics to sulfur dioxide. Toxicol Ind Health 2 (1986) 289-298
17. Tunnicliffe W.S., Harrison R.M., Kelly F.J., Dunster C., and Ayres J.G. The effect of sulphurous air pollutant exposures on symptoms, lung function, exhaled nitric oxide, and nasal epithelial lining fluid antioxidant concentrations in normal and asthmatic adults. Occup Environ Med 60 (2003) e1-e7
18. Triche E.W., Belanger K., Bracken M.B., Beckett W.S., Holford T.R., Gent J.F., et al. Indoor heating sources and respiratory symptoms in nonsmoking women. Epidemiology 16 (2005) 377-384
19. Weaver L.K., Hopkins R.O., Chan K.J., Churchill S., Elliott C.G., Clemmer T.P., et al. Hyperbaric oxygen for acute carbon monoxide poisoning. N Engl J Med 347 (2002) 1057-1067
20. Burnett R.T., Dales R.E., Brook J.R., Raizenne M.E., and Krewski D. Association between ambient carbon monoxide levels and hospitalizations for congestive heart failure in the elderly in 10 Canadian cities. Epidemiology 8 (1997) 162-167
21. Pouli A.E., Hatzinikolaou D.G., Piperi C., et al. The cytotoxic effect of volatile organic compounds of the gas phase of cigarette smoke on lung epithelial cells. Free Radic Biol Med 34 (2003) 345-355
22. Wolkoff P., Wilkins C.K., Clausen P.A., and Nielsen G.D. Organic compounds in office environments: sensory irritation, odor, measurements and the role of reactive chemistry. Indoor Air 16 (2006) 7-19
23. Cometto-Muniz J.E., Cain W.S., and Abraham M.H. Detection of single and mixed VOCs by smell and by sensory irritation. Indoor Air 14 suppl 8 (2004) 108-117
24. Bluyssen P., DeOliveiro Fernandes E., Groes L., Clausen G., Fanger P., Valbjorn O., et al. European indoor air quality audit project in 56 office buildings. Indoor Air 6 (1996) 221-238
25. Wilkins C.K., and Larsen K. Identification of volatile microbiological compounds from household waste and building materials by thermal desorption-capillary gas chromatography-mass spectroscopy. J High Resol Chromatogr 18 (1995) 373-377
26. Park J.H., Schleiff P.L., Attfield M.D., et al. Building-related respiratory symptoms can be predicted with semi-quantitative indices of exposure to dampness and mold. Indoor Air 14 (2004) 425-433
27. Korpi A., Pasanen A.-L., and Pasanen P. Volatile compounds originating from mixed microbial cultures on building materials under various humidity conditions. Appl Environ Microbiol 64 (1998) 2914-2919
28. Smedje G., Norbäck D., Wessen B., and Edling C. Asthma among school employees in relation to the school environment. Proceedings of Indoor Air '96 Vol 1 (1996), Seec Ishibashi Inc, Tokyo 611-616
29. Wålinder R., Wieslander G., and Norbäck D. Nasal lavage biomarkers: effects of water damage and microbial growth in an office building. Arch Environ Health 56 (2001) 30-36
30. Wålinder R., Ernstrgård L., Johanson G., Norbäck D., Venge P., and Wieslander G. Acute effects of a fungal volatile compound. Environ Health Perspect 113 (2005) 1775-1778
31. Larsen F.O., Clementsen P., Hansen M., et al. Volatile organic compounds from the indoor mould Trichoderma viride cause histamine release from human bronchoalveolar cells. Inflamm Res 47 suppl 1 (1998) 5-6
32. Wålinder R., Norbäck D., and Johanson G. Pulmonary reactions after exposure to 3-methylfuran vapour, a fungal metabolite. Int J Tuberc Lung Dis 2 (1998) 1037-1039
33. Janson C. The effect of passive smoking on respiratory health in children and adults. Int J Tuberc Lung Dis 8 (2004) 510-516
34. Brownson R.C., Figgs L.W., and Caisley L.E. Epidemiology of environmental tobacco smoke exposure. Oncogene 21 (2002) 7341-7348
35. Rushton L. Health impact of environmental tobacco smoke in the home. Rev Environ Health 19 (2004) 291-309
36. Jaakkola M.S., and Jaakkola J.J. Effects of environmental tobacco smoke on the respiratory health of adults. Scand J Work Environ Health 28 suppl (2002) 52-70
37. Jaakkola M.S., and Jaakkola J.J. Effects of environmental tobacco smoke on the respiratory health of children. Scand J Work Environ Health 28 suppl (2002) 71-83
38. Cook D.G., Strachan D.P., and Carey I.M. Health effects of passive smoking. 9. Parental smoking and spirometric indices in children. Thorax 53 (1998) 884-893
39. Delfino R.J. Epidemiologic evidence for asthma and exposure to air toxics: linkages between occupational, indoor, and community air pollution research. Environ Health Perspect 110 (2002) 573-589
40. Weisel C.P. Assessing exposure to air toxics relative to asthma. Environ Health Perspect 110 (2002) 527-537
41. D'Amato G. Environmental risk factors and allergic bronchial asthma. Clin Exp Allergy 35 (2005) 1113-1124
42. Donaldson K., Brown D., Clouter A., Duffin R., MacNee W., Renwick L., et al. The pulmonary toxicology of ultrafine particles. J Aerosol Med 15 (2002) 213-220
43. Ogulei D., Hopke P.K., and Wallace L.A. Analysis of indoor particles size distributions in an occupied townhouse using positive matrix factorization. Indoor Air 16 (2006) 204-215
44. Weichenthal S., Dufresne A., Infante-Rivard C., and Joseph L. Indoor ultrafine particle exposures and home heating systems: a cross-sectional survey of Canadian homes during the winter months. J Expo Sci Environ Epidemiol 17 (2006) 288-297
45. Simoni M., Carrozzi L., Baldacci S., Scognamiglio A., Di Pede F., Sapigni T., et al. The Po River Delta (north Italy) indoor epidemiological study: effects of pollutant exposure on acute respiratory symptoms and respiratory function in adults. Arch Environ Health 57 (2002) 130-136
46. Ormstad H. Suspended particulate matter in indoor air: adjuvants and allergen carriers. Toxicology 152 (2000) 53-68
47. Leung T.F., Lam C.W., Chan I.H., Li A.M., Ha G., Tang N.L., et al. Inhalant allergens as risk factors for the development and severity of mild-to-moderate asthma in Hong Kong Chinese children. J Asthma 39 (2002) 323-330
48. van Vliet P., Knape M., de Hartog J., Janssen N., Harssema H., and Brunekreef B. Motor vehicle exhaust and chronic respiratory symptoms in children living near freeways. Environ Res 74 (1997) 122-132
49. Diaz-Sanchez D., Tsien A., Fleming J., and Saxon A. Combined diesel exhaust particulate and ragweed allergen challenge markedly enhances human in vivo nasal ragweed-specific IgE and skews cytokine production to a T helper cell 2-type pattern. J Immunol 158 (1997) 2406-2413
50. Leem J.H., Kim J.H., Lee K.H., Hong Y., Lee K.H., Kang D., et al. Asthma attack associated with oxidative stress by exposure to ETS and PAH. J Asthma 42 (2005) 463-467
51. Li N., Sioutas C., Cho A., Schmitz D., Misra C., Sempf J., et al. Ultrafine particulate pollutants induce oxidative stress and mitochondrial damage. Environ Health Perspect 111 (2003) 455-460
52. Thorn A. The sick building syndrome: a diagnostic dilemma. Soc Sci Med 47 (1998) 1307-1312
53. Menzies D., Popa J., Hanley J.A., et al. Effect of ultraviolet germicidal lights installed in office ventilation systems on workers' health and well-being: double-blind multiple crossover trial. Lancet 362 (2003) 1785-1791
54. Nevalainen A., Pasanen A.-L., Niininen M., Reponen T., Jantunen M.J., and Kalliokoski P. The indoor air quality in Finnish homes with mold problems. Environ Int 17 (1991) 299-302
55. IOM (Institute of Medicine) Damp Indoor Spaces and Health (2004), National Academy of Sciences, Washington (DC)
56. Portnoy J.M., Kwak K., Dowling P., VanOsdol T., and Barnes C. Health effect of indoor fungi. Ann Allergy Asthma Immunol 94 (2005) 313-319
57. Bush R.K., Portnoy J.M., Saxon A., Terr A.I., and Wood R.A. The medical effects of mold exposure. J Allergy Clin Immunol 117 (2006) 326-333
58. Green B.J., Mitakakis T.Z., and Tovey E.R. Allergen detection from 11 fungal species and after germination. J Allergy Clin Immunol 111 (2003) 285-289
59. Rylander R. (1→3)-β-D-glucan in the environment: a risk assessment. In: Young S.-H., and Castranova V. (Eds). Toxicity of (1-3)-β-glucans (2005), CRC Press, Boca Raton (FL) 53-64
60. Burge H.A. Fungi: toxic killers or unavoidable nuisances?. Ann Allergy Asthma Immunol 87 (2002) 52-56
61. Górny R.L., Reponen T., Willeke K., Robine E., Boissier M., and Grinshpun S.A. Fungal fragments as indoor biocontaminants. Appl Environ Microbiol 68 (2002) 3522-3531
62. Brasel T.L., Douglas D.R., Wilson S.C., and Straus D.C. Detection of airborne Stachybotrys chartarum macrocyclic trichothecene mycotoxins on particulates smaller than conidia. Appl Environ Microbiol 71 (2005) 114-122
63. Cho S.-H., Seo S.-C., Schmechel D., Grinshpun S.A., and Reponen T. Aerodynamic characteristics and respiratory deposition of fungal fragments. Atmos Environ 39 (2005) 5454-5465
64. Taskinen T., Meklin T., Nousiainen M., Husman T., Nevalainen A., and Korppi M. Moisture and mould problems in schools and respiratory manifestation in schoolchildren: clinical and skin test findings. Acta Pediatr 86 (1997) 1181-1187
65. Bobbitt R.C., Crandall M., Venkataraman A., and Bernstein J.A. Characterization of a population presenting with suspected mold-related health effects. Ann Allergy Asthma Immunol 94 (2005) 39-44
66. Iossifova Y., Reponen T., Bernstein D., Levin L., Zeigler H., Kalra H., et al. House dust (1-3)-β-d-glucan and wheezing in infants. Allergy 62 (2007) 504-513
67. Schram-Bijkerk D., Doekes G., Douwes J., Boeve M., Riedler J., Ublagger E., et al. Bacterial and fungal agents in house dust and wheeze in children: the PARSIFAL study. Clin Exp Allergy 35 (2005) 1272-1278
68. Johanning E., Biagini R., DeLon H., Morey P., Jarvis B., and Landsbergis P. Health and immunology study following exposure to water-damaged office environment. Int Arch Occup Environ Health 68 (1996) 207-218
69. Etzel R.A., Montana E., Sorenson W.G., Kullman G.J., Allan T.T., and Dearborn D.G. Acute pulmonary hemorrhage in infants associated with exposure to Stachybotrys atra and other fungi. Arch Pediatr Adolesc Med 152 (1998) 757-762
70. Hodgson M.J., Morey P., Leung W.-Y., Morrow L., Miller D., Jarvis B.B., et al. Building-associated pulmonary disease from exposure to Stachybotrys chartarum and Aspergillus versicolor. J Occup Environ Med 40 (1998) 241-249
71. CDC. Update: pulmonary hemorrhage/hemosiderosis among infants: Cleveland Ohio 1993-1996. Morb Mortal Wkly Rep 49 (2000) 180-185
72. Rao C.Y., Burge H.A., and Brain J.D. The time course of responses to intratracheally instilled toxic Stachybotrys atra spores in rats. Mycopathologia 149 (2000) 27-34
73. American Conference of Governmental Industrial Hygienists. Bioaerosols: Assessment and Control (2004), ACGIH, Cincinnati (OH)
74. Flannigan B. Guidelines for evaluation of airborne microbial contamination of buildings. In: Johanning E., and Yang C. (Eds). Fungi and bacteria in indoor environments (1995), Eastern New York Occupational Health Program, Latham 123-130
75. Chriqui J.F., Frosh M., Brownson R.C., Shelton D.M., Sciandra R.C., Hobart R., et al. Application of a rating system to state clean indoor air laws (USA). Tob Control 11 (2002) 26-34
76. Moglia D., Smith A., MacIntosh D.L., and Somers J.L. Prevalence and implementation of IAQ programs in US schools. Environ Health Perspect 114 (2006) 141-146